title: Compression of coated drug beads for sustained release tablet of glipizide: formulation, and dissolution.
abstract: A promising glipizide formulation comprising compression of four-layer coated beads into tablets was prepared. The tablet offered the advantages of: a two-hour lag time before drug release, retaining sustained release characteristics and providing approximately zero-order drug release. Drug release was nearly independent of paddle speeds of 50 and 100 rpm releasing 80% over 14 h similar to the commercial glipizide osmotic pump tablet during dissolution testing while keeping the benefits of multiparticular dosage forms. The tablets contain beads with four layers: (1) the innermost layer consists of 2.5 g glipizide and 3.75 g solid ethylcellulose (Surelease®) coated onto 71.25 g of sugar beads; (2) next a hardening layer of 5 g of hypromellose; (3) the controlled release layer of 7.5 g of Surelease®:lactose at a solids ratio of 100:7 and (4) an outermost layer of 20 g of lactose:sodium starch glycolate (Explotab®) at a 2:1 ratio. Then, beads were compressed into tablets containing 11 mg of glipizide using 1500 lbs of compression pressure. The dissolution test similarity factor (f2) was above 50 for all test conditions for formulation F13 and Glucotrol® with a high of 69.9. The two Surelease® layers both aid controlling drug release, with the Surelease®-drug layer affecting drug release to a greater extent.
authors.affiliation: Industrial Department of Pharmacy, Hanoi University of Pharmacy , Hanoi , Vietnam.
authors.forename: Chien
authors.initials: C
authors.lastname: Nguyen
authors.forename: J Mark
authors.initials: JM
authors.lastname: Christensen
authors.forename: James W
authors.initials: JW
authors.lastname: Ayres
mesh_terms: D002482:Cellulose / Q000031:analogs & derivatives / Q000737:chemistry; D003692:Delayed-Action Preparations / Q000737:chemistry*; D004339:Drug Compounding; D005913:Glipizide / Q000008:administration & dosage*; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D065347:Hypromellose Derivatives; D007785:Lactose / Q000737:chemistry; D008747:Methylcellulose / Q000031:analogs & derivatives / Q000737:chemistry; D012995:Solubility; D013213:Starch / Q000031:analogs & derivatives / Q000737:chemistry; D013607:Tablets
chemical_list: D003692:Delayed-Action Preparations; D007004:Hypoglycemic Agents; D013607:Tablets; D065347:Hypromellose Derivatives; C013517:ethyl cellulose; D002482:Cellulose; D008747:Methylcellulose; D013213:Starch; C048390:sodium starch glycolate; D007785:Lactose; D005913:Glipizide